Have a personal or library account? Click to login
CD63 and Dna Mismatch Repair Protein Expression in Prostate Cancer Cover

CD63 and Dna Mismatch Repair Protein Expression in Prostate Cancer

Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences.
Volume 75 (2021): Issue 3 (June 2021)
By: Kristofs Folkmanis,  Jānis Eglītis,  Māris Jakubovskis,  Vilnis Lietuvietis,  Inese Folkmane and  Sergejs Isajevs  
Open Access
|Jul 2021

Authors

Kristofs Folkmanis

kristofs87@inbox.lv

Faculty of Medicine, University of Latvia, Latvia
St. Bonifatius Hospital, Germany

Jānis Eglītis

Faculty of Medicine, University of Latvia, Latvia
Rīga East University Clinical Hospital, Latvia

Māris Jakubovskis

Rīga East University Clinical Hospital, Latvia
Rīga Stradiņš University, Latvia

Vilnis Lietuvietis

Rīga East University Clinical Hospital, Latvia
Rīga Stradiņš University, Latvia

Inese Folkmane

Faculty of Medicine, University of Latvia, Latvia

Sergejs Isajevs

Faculty of Medicine, University of Latvia, Latvia
Rīga East University Clinical Hospital, Latvia
DOI: https://doi.org/10.2478/prolas-2021-0027 | Journal eISSN: 2255-890X | Journal ISSN: 1407-009X
Journal RSS Feed
Language: English
Page range: 180 - 185
Submitted on: Nov 2, 2020
Accepted on: Jan 14, 2021
Published on: Jul 22, 2021
Published by: Latvian Academy of Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year
Keywords:
CD63 exosomal biomarker,
mismatch repair protein biomarkers,
mismatch repair pathway deficiency,
immunohistochemistry,
prostate acinar adenocarcinoma,
benign prostate hyperplasia
Related subjects:
General interest,
Mathematics,
General mathematics

© 2021 Kristofs Folkmanis, Jānis Eglītis, Māris Jakubovskis, Vilnis Lietuvietis, Inese Folkmane, Sergejs Isajevs, published by Latvian Academy of Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 75 (2021): Issue 3 (June 2021)Next article